Post by Alvotech

This week at the Jefferies Global Healthcare Conference, our Chairman and Founder, Róbert Wessman, and Chief Strategy Officer, Dr Balaji V Prasad, discussed Alvotech’s progress, strategy and outlook with investors. The conversation highlighted the significance of the recent resubmission of our Biologics License Applications for two biosimilar candidates in the U.S., our growing global commercial footprint, and the opportunities ahead as we continue to advance one of the industry’s broadest biosimilar pipelines. Thank you to everyone who joined the discussion. 🎧Listen here: https://lnkd.in/eQicav4T #Biosimilars #Biologics #Healthcare #Biotech #Investing